Quoin Pharmaceuticals Exceeds Q4 Earnings Expectations
Quoin Pharmaceuticals' Q4 Earnings Report Unveiled On March 13, 2024, Quoin Pharmaceuticals (NASDAQ: QNRX) disclosed its Q4 earnings, shedding light ...
Tag: QNRX
AnaptysBio Receives Upgrade from Wedbush Shares Surge
AnaptysBio's shares have surged following an upgrade from Wedbush, who raised their rating from Neutral to Outperform. Analysts are bullish ...
Quoin Pharmaceuticals Receives FDA Approval for Teenage Trials of QRX003 for Netherton Syndrome
Quoin Pharmaceuticals has recently been granted FDA approval to enroll teenagers in placebo and open-label trials for QRX003, a promising ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
